Egyptian Journal of Hematology and Bone Marrow Transplantation最新文献

筛选
英文 中文
Correlation and outcome of Vitamin D polymorphism in Primary Immune Thrombocytopenic purpura patients under Eltrombopag therapy 原发性免疫性血小板减少性紫癜患者维生素D多态性的相关性及预后
Egyptian Journal of Hematology and Bone Marrow Transplantation Pub Date : 2023-04-01 DOI: 10.21608/ejhbmt.2023.318009
Walaa El Salakawy, Rasha Said, Doaa Abd Elaziz, Rana Abbas, Basma Ali, Rana Hamdy
{"title":"Correlation and outcome of Vitamin D polymorphism in Primary Immune Thrombocytopenic purpura patients under Eltrombopag therapy","authors":"Walaa El Salakawy, Rasha Said, Doaa Abd Elaziz, Rana Abbas, Basma Ali, Rana Hamdy","doi":"10.21608/ejhbmt.2023.318009","DOIUrl":"https://doi.org/10.21608/ejhbmt.2023.318009","url":null,"abstract":"Background: Primary Immune thrombocytopenia (ITP) is an autoimmune disease characterized by both platelet destruction and impaired platelet production. Vitamin D regulates the growth and differentiation of various cells of the immune system through acting on vitamin D receptors (VDRs) expressed on these immune cells. Studies have demonstrated the role of VDR polymorphisms in the development of various autoimmune diseases. Aim of the Work To find the correlation between vitamin D receptor gene polymorphism and outcome in primary and resistant immune thrombocytopenic patients under Eltrombopag therapy.","PeriodicalId":482748,"journal":{"name":"Egyptian Journal of Hematology and Bone Marrow Transplantation","volume":"56 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135771692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Homocysteine as a Screening and Diagnostic Indicator for Assessing Diabetic Retinopathy Risk in Patients with Diabetes Mellitus 同型半胱氨酸作为评估糖尿病视网膜病变风险的筛查和诊断指标
Egyptian Journal of Hematology and Bone Marrow Transplantation Pub Date : 2023-04-01 DOI: 10.21608/ejhbmt.2023.318013
Raef Botros, Ahmed Bahaa Eldin, Hany mansour, Nesma Ahmed, Mona El-deep
{"title":"Homocysteine as a Screening and Diagnostic Indicator for Assessing Diabetic Retinopathy Risk in Patients with Diabetes Mellitus","authors":"Raef Botros, Ahmed Bahaa Eldin, Hany mansour, Nesma Ahmed, Mona El-deep","doi":"10.21608/ejhbmt.2023.318013","DOIUrl":"https://doi.org/10.21608/ejhbmt.2023.318013","url":null,"abstract":"Background: Diabetes mellitus is a set of metabolic diseases characterized by chronic hyperglycemia as a consequence of lack in insulin action, secretion, or both. Diabetic retinopathy (DR) is a major complication of diabetes mellitus (DM), which remains a leading cause of visual loss in working-age populations. Aim of the Work: We aim to investigate plasma homocysteine as a screening and diagnostic indicator for assessing diabetic retinopathy (DR) risk in patients with diabetes mellitus. Patients and Methods: This was an observational study which was conducted on 90 diabetic patients at diabetes outpatient clinic at Ain Shams University Hospital, to investigate plasma homocysteine as a screening and diagnostic indicator for assessing diabetic retinopathy (DR) risk in patients with diabetes mellitus. Results: Our study shows that there was a high statistically significant difference between the studied groups regarding (age of the patient and duration of diabetes mellitus) also clinical data (HTN, SBP and DBP) also laboratory data (FBS, HBA1C, eGFR and albumin /creatinine ratio). The study also shows that there was a high statistically significant difference between the studied groups regarding homocysteine level. In our study there was positive correlation found between homocysteine level and (age, duration of diabetes, HbA1C and FBG, eGFR and ACR). In addition, there was no statistically significant difference between the studied groups regarding (gender, smoking and BMI). Conclusion:","PeriodicalId":482748,"journal":{"name":"Egyptian Journal of Hematology and Bone Marrow Transplantation","volume":"14 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135771702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bax, Bcl-2, and Bax/Bcl-2 as prognostic markers in adults Acute myeloid Leukemia Patients Bax、Bcl-2和Bax/Bcl-2作为成人急性髓性白血病患者的预后指标
Egyptian Journal of Hematology and Bone Marrow Transplantation Pub Date : 2023-04-01 DOI: 10.21608/ejhbmt.2023.318016
mohamed Hamdy, Mostafa El-Razzaz, Heba Saber, Gehad Fekry, Ahmed Ali
{"title":"Bax, Bcl-2, and Bax/Bcl-2 as prognostic markers in adults Acute myeloid Leukemia Patients","authors":"mohamed Hamdy, Mostafa El-Razzaz, Heba Saber, Gehad Fekry, Ahmed Ali","doi":"10.21608/ejhbmt.2023.318016","DOIUrl":"https://doi.org/10.21608/ejhbmt.2023.318016","url":null,"abstract":"Background: Acute myeloid leukemia (AML) is a type of leukemia that is characterized by infiltration of the bone marrow, blood, and other tissues by abnormally differentiated cells of the hematopoietic system. It is also considered a heterogeneous disease with respect to clinical presentations and outcomes. AML is characterized by accumulation of several acquired genetic abnormalities and epigenetic changes. Although 60 – 80% of AML patients achieve a complete remission, the majority of them relapse later on and the 5-year survival rate is very low. This shows the necessary need for new early diagnostic and prognostic biomarkers together with novel treatment options.","PeriodicalId":482748,"journal":{"name":"Egyptian Journal of Hematology and Bone Marrow Transplantation","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135771712","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书